Senseonics Holdings Inc (SENS)
0.32
0.00 (0.00%)
USD |
NYAM |
Nov 22, 14:03
Senseonics Holdings Shareholders Equity (Quarterly): -17.18M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -17.18M |
June 30, 2024 | 0.578M |
March 31, 2024 | 18.96M |
December 31, 2023 | 35.80M |
September 30, 2023 | 52.06M |
June 30, 2023 | 52.54M |
March 31, 2023 | 64.46M |
December 31, 2022 | -2.576M |
September 30, 2022 | -15.06M |
June 30, 2022 | 15.94M |
March 31, 2022 | -89.47M |
December 31, 2021 | -185.54M |
September 30, 2021 | -266.65M |
June 30, 2021 | -312.64M |
March 31, 2021 | -185.90M |
December 31, 2020 | -144.08M |
September 30, 2020 | -54.78M |
June 30, 2020 | -39.60M |
March 31, 2020 | -48.96M |
December 31, 2019 | -8.649M |
Date | Value |
---|---|
September 30, 2019 | 25.35M |
June 30, 2019 | 15.17M |
March 31, 2019 | 43.94M |
December 31, 2018 | 71.26M |
September 30, 2018 | 76.60M |
June 30, 2018 | 105.72M |
March 31, 2018 | -13.17M |
December 31, 2017 | 7.267M |
September 30, 2017 | 22.25M |
June 30, 2017 | 12.03M |
March 31, 2017 | -16.84M |
December 31, 2016 | -4.877M |
September 30, 2016 | 4.225M |
June 30, 2016 | 14.46M |
March 31, 2016 | 20.61M |
September 30, 2015 | -0.0473M |
June 30, 2015 | -0.0455M |
March 31, 2015 | -0.0039M |
December 31, 2014 | -0.0022M |
September 30, 2014 | -0.0146M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-312.64M
Minimum
Jun 2021
64.46M
Maximum
Mar 2023
-56.54M
Average
-16.12M
Median
Shareholders Equity (Quarterly) Benchmarks
Abbott Laboratories | 39.80B |
DexCom Inc | 1.979B |
Baxter International Inc | 7.872B |
Boston Scientific Corp | 20.71B |
Perspective Therapeutics Inc | 328.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 96.33M |
Total Liabilities (Quarterly) | 113.51M |
Debt to Equity Ratio | -3.133 |
Current Ratio | 2.470 |
Net Debt Paydown Yield | -1.54% |